Artax Biopharma, Inc. — Form D/A

Artax Biopharma, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2026-05-05. The offering totals $19.0M, of which $19.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Robert W. Armstrong, Ph.D.Related PersonCambridge, MA
Casper BreumRelated PersonNESS ZIONA, L3
Andre HoekemaRelated PersonCambridge, MA
Maria NicholRelated PersonCambridge, MA
Raj ParekhRelated PersonWaltham, MA
Gino SantiniRelated PersonCambridge, MA
Joe SuarezRelated PersonCambridge, MA
Damia Tormo, Ph.D.Related PersonCambridge, MA
Alan WaltsRelated PersonCambridge, MA
Damia W Tormo, Ph.D.DirectorCambridge, MA
Alan W WaltsDirectorCambridge, MA
Raj W ParekhDirectorCambridge, MA
Robert W Armstrong, Ph.D.DirectorCambridge, MA
Robert W Armstrong, Ph.D.Executive OfficerCambridge, MA
Joe W SuarezExecutive OfficerCambridge, MA
Andre W HoekemaDirectorCambridge, MA
Maria W NicholExecutive OfficerCambridge, MA
Casper W BreumDirectorCambridge, MA
Gino W SantiniDirectorCambridge, MA
Gino SantiniDirectorCambridge, MA
Robert ArmstrongDirectorCambridge, MA
Robert ArmstrongExecutive OfficerCambridge, MA
Damia TormoDirectorCambridge, MA
Damia TormoExecutive OfficerCambridge, MA
Casper BreumDirectorNESS ZIONA, L3

Other filings by this issuer (10)

FiledFormOfferingSold
2025-07-29D/A$11.0M$11.0M
2024-08-09D$8.0M$6.0M
2022-05-18D/A$25.8M$25.8M
2022-01-03D$23.2M$12.7M
2021-02-26D$3.0M$2.2M
2020-05-04D$2.0M$2.0M
2019-08-12D$3.5M$750K
2015-10-27D$10.0M$3.0M
2014-11-10D$2.0M$2.0M
2013-09-25D$2.0M$1.3M

More